关注
Erik Nutma
Erik Nutma
Postdoctoral Researcher, Biomedical Primate Research Center
在 bprc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Inflammation in CNS neurodegenerative diseases
J Stephenson, E Nutma, P van der Valk, S Amor
Immunology 154 (2), 204-219, 2018
8192018
Astrocyte and oligodendrocyte cross-talk in the central nervous system
E Nutma, D van Gent, S Amor, LAN Peferoen
Cells 9 (3), 600, 2020
1222020
Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders
J Bryois, D Calini, W Macnair, L Foo, E Urich, W Ortmann, VA Iglesias, ...
Nature neuroscience 25 (8), 1104-1112, 2022
1142022
Cellular sources of TSPO expression in healthy and diseased brain
E Nutma, K Ceyzériat, S Amor, S Tsartsalis, P Millet, DR Owen, ...
European journal of nuclear medicine and molecular imaging, 1-18, 2021
1122021
Microglial autophagy–associated phagocytosis is essential for recovery from neuroinflammation
R Berglund, AO Guerreiro-Cacais, MZ Adzemovic, M Zeitelhofer, H Lund, ...
Science immunology 5 (52), eabb5077, 2020
1032020
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
E Nutma, JA Stephenson, RP Gorter, J de Bruin, DM Boucherie, CK Donat, ...
Brain 142 (11), 3440-3455, 2019
982019
Neuroimmunology–the past, present and future
E Nutma, H Willison, G Martino, S Amor
Clinical & Experimental Immunology 197 (3), 278-293, 2019
712019
Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain
E Nutma, E Gebro, MC Marzin, P van der Valk, PM Matthews, DR Owen, ...
Glia 69 (10), 2447-2458, 2021
602021
White matter microglia heterogeneity in the CNS
S Amor, NB McNamara, E Gerrits, MC Marzin, SM Kooistra, VE Miron, ...
Acta Neuropathologica 143 (2), 125-141, 2022
542022
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
E Nutma, N Fancy, M Weinert, S Tsartsalis, MC Marzin, RCJ Muirhead, ...
Nature communications 14 (1), 5247, 2023
472023
Transmembrane protein 119 is neither a specific nor a reliable marker for microglia
E Vankriekelsvenne, U Chrzanowski, K Manzhula, T Greiner, A Wree, ...
Glia 70 (6), 1170-1190, 2022
392022
Brain macrophages acquire distinct transcriptomes in multiple sclerosis lesions and normal appearing white matter
A Miedema, E Gerrits, N Brouwer, Q Jiang, L Kracht, M Meijer, E Nutma, ...
Acta neuropathologica communications 10 (1), 8, 2022
332022
Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes
RP Gorter, J Stephenson, E Nutma, J Anink, JC de Jonge, W Baron, ...
Neuropathology and applied neurobiology 45 (5), 459-475, 2019
262019
Synaptic loss in multiple sclerosis spinal cord
N Petrova, E Nutma, D Carassiti, J RS Newman, S Amor, DR Altmann, ...
Annals of neurology 88 (3), 619-625, 2020
242020
Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis
RP Gorter, E Nutma, MC Jahrei, JC de Jonge, RA Quinlan, P van der Valk, ...
Clinical & Experimental Immunology 194 (2), 137-152, 2018
182018
Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model
D Baker, E Nutma, H O'Shea, A Cooke, JM Orian, S Amor
Annals of Clinical and Translational Neurology 6 (8), 1362-1372, 2019
172019
Myeloid cell‐specific topoisomerase 1 inhibition using DNA origami mitigates neuroinflammation
K Zhu, Y Wang, H Sarlus, K Geng, E Nutma, J Sun, SY Kung, C Bay, ...
EMBO reports 23 (7), e54499, 2022
152022
Single nuclei RNAseq stratifies multiple sclerosis patients into distinct white matter glial responses
W Macnair, D Calini, E Agirre, J Bryois, S Jäkel, P Kukanja, N Stokar, V Ott, ...
BioRxiv, 2022.04. 06.487263, 2022
122022
Autophagy in white matter disorders of the CNS: Mechanisms and therapeutic opportunities
E Nutma, MC Marzin, SAGM Cillessen, S Amor
The Journal of Pathology 253 (2), 133-147, 2021
102021
Brain endothelial cell expression of SPARCL‐1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro
C Bridel, MJA Koel‐Simmelink, L Peferoen, C Derada Troletti, S Durieux, ...
Neuropathology and applied neurobiology 44 (4), 404-416, 2018
102018
系统目前无法执行此操作,请稍后再试。
文章 1–20